-
Real-World Effectiveness of Immune Checkpoint Inhibitors Chemotherapy (ICI+CT) vs. ICI Monotherapy (ICI) in Untreated Locally Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Evolving Assumptions on Treatment Durability in Cost-Effectiveness Models of Cell and Gene Therapies: Insights From French HTA Submissions
Sep 9, 2025, 16:22 PM -
Understanding the Consequences of International Reference Pricing on Cancer Immunotherapy in Europe: A 10-Year Price Corridor Analysis
Sep 9, 2025, 16:22 PM -
Improving the Transferability of Global RCT Data to Inform Cost-Effectiveness Models in Japan: A Structured Framework for C2H Submissions
Sep 9, 2025, 16:22 PM -
The Changing Prevalence of Multicomorbid Patients in the US
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Synovial Biopsy-Guided Treatment Strategy After TNF-Alpha Inhibitor Failure in Rheumatoid Arthritis
Sep 9, 2025, 16:22 PM -
Beyond the Guidelines: Exploring the Characteristics and Comorbidity Profiles of Adults With Pneumococcal Disease in England Not Covered by Current Pneumococcal Vaccination Criteria
Sep 9, 2025, 16:22 PM -
US PIE and AMCP Dossiers: Payer Preferences Best Practice and a Comparison With Global Evidence Dossiers
Sep 9, 2025, 16:22 PM -
Sex Differences in Characteristics and Treatment Patterns of Patients With Sleep Disorders in South Korea
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Cefiderocol for the Treatment of Confirmed MBL-Producing Pathogens in Italy
Sep 9, 2025, 16:22 PM -
Estimating Health Utility Decrements Associated With Chronic Disease Outcomes Using MEPS
Sep 9, 2025, 16:22 PM -
The Interim Acceptance and Ultraorphan Pathways in Scotland: An Update
Sep 9, 2025, 16:22 PM -
Adherence to Anti-VEGF Treatment of Patients With Age-Related Macular Degeneration of Exudative Type (nAMD) and Diabetic Macular Edema (DME) in Greece: Evidence From an Expert Panel
Sep 9, 2025, 16:22 PM -
Components of the Direct Cost of Topical Treatment for Chronic Wounds in Adults and Elderly: A Systematic Review
Sep 9, 2025, 16:22 PM -
Distributional Cost-Effectiveness Analysis Across the Globe: How Feasible Is It Really?
Sep 9, 2025, 16:22 PM -
How Far Have We Come With EQ-5D-5L Value Sets? An Updated Systematic Literature Review of 55 Valuation Studies
Sep 9, 2025, 16:22 PM -
Studying Paternal Drug Exposures and Offspring Outcomes: A Feasibility Assessment of 11 Large European Databases
Sep 9, 2025, 16:22 PM -
A Budget Impact Model of Switching From Self-Monitoring of Blood Glucose to Continuous Glucose Monitoring for Individuals With Type 2 Diabetes Mellitus Receiving Basal Insulin in Italy
Sep 9, 2025, 16:22 PM -
The Impact of the Introduction of Diagnosis-Related Groups (DRG)-Based Hospital Financing on the Performance of Romanian Hospitals
Sep 9, 2025, 16:22 PM -
Comprehensive Clinical Evaluation of Drugs for Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Sep 9, 2025, 16:22 PM
